The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial

Aim: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) forms a significant component of oxidised LDL. The effects of exercise on levels of MDA-LDL and anti-MDA-LDL antibodies are not well-understood. Furthermore, it is not known whether these can be modified in patients with coronary artery...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Adam Hartley, Matthew Shun-Shin, Mikhail Caga-Anan, Christopher Rajkumar, Alexandra N. Nowbar, Michael Foley, Darrel P. Francis, Dorian O. Haskard, Ramzi Y. Khamis, Rasha K. Al-Lamee
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-10-01
coleção:	Frontiers in Cardiovascular Medicine
Assuntos:	atherosclerosis percutaneous coronary intervention (PCI) exercise LDL-cholesterol oxidised LDL (oxLDL) malondialdehyde-modified LDL (MDA-LDL)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.757030/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!